Announced Fri, 19 Jun · 10:48 IST
Invesco MF acquires 0.47% in Corona Remedies; holding rises to 5.06%
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹1832.40
prior close
₹1849.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0+0.0-0.1+0.9+4.0+5.8+4.0+7.3+6.8+12.4+11.4——
Up moveDown movePending
AI summary
Invesco Mutual Fund bought 2,89,017 equity shares (0.47%) of Corona Remedies via open market on June 17, 2026. Aggregate holding across 6 schemes rose from 4.58% to 5.06%, crossing the 5% SEBI SAST disclosure threshold. Acquisition was made as non-promoter through open market purchase.
Likely market impact
Crossing 5% signals continued institutional buying interest. Positive sentiment cue, but mutual fund is not a promoter so no takeover trigger.